Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome
Modi MB, Donga SB, Dei L
Ayu · 9 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Randomized controlled trial (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2012-01-01 · Ayu · vol. 33 · issue 4 · p. 511
- Publisher
- Medknow
- Cited
- 34 citations · more than 85% of similar papers · 0.9× the field average
- References
- 11 works
- Access
- Open access (repository copy) · CC-BY-NC-SA
- Research areas
- Phytochemicals and Medicinal Plants · Menopause: Health Impacts and Treatments · Pharmacological Effects of Medicinal Plants
- Keywords
- Menopause, Medicine, Rating scale, Quality of life (healthcare), Physical therapy, Clinical trial, Wilcoxon signed-rank test, Randomized controlled trial, Gynecology, Internal medicine, Mann–Whitney U test, Psychology
3 authors
From IN
- MansiB Modi · corresponding
- ShilpaB DongaGujarat Ayurved University
- Laxmipriya DeiGujarat Ayurved University
Abstract
Menopause is a gradual and natural transitional phase of adjustment between the active and inactive ovarian function and occupies several years of a women's life and involves biological and psychological changes adjustments. The present clinical trial was designed as per Ayurveda clinical trials protocol to evaluate the efficacy of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome. It was directed by Central Council for Research in Ayurvedic Sciences as randomized open clinical trial. Total 52 patients were registered in the study, out of which 51 patients completed the study. Specialized rating scales like Kupperman Index Score as well as Menopause Rating Scale (MRS) and Menopause Specific Quality of Life (MENQOL) questionnaires were adopted for diagnostic as well as assessment criteria. The effects were examined based on MRS and MENQOL. Results were analyzed statistically using Wilcoxon matched paired test and 't' test. Highly significant (P < 0.01) reduction was found in the symptoms of MRS as well as MENQOL. Finally, it can be stated that combined treatment of above drugs gives better result in both somatic as well as psychological complaints in women with mild to moderate symptoms of menopausal syndrome.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-SA).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.